Year |
Citation |
Score |
2023 |
Pyun J, Koay H, Runwal P, Mawal C, Bush AI, Pan Y, Donnelly PS, Short JL, Nicolazzo JA. Cu(ATSM) Increases P-Glycoprotein Expression and Function at the Blood-Brain Barrier in C57BL6/J Mice. Pharmaceutics. 15. PMID 37631298 DOI: 10.3390/pharmaceutics15082084 |
0.346 |
|
2022 |
Pan Y, Kagawa Y, Sun J, Turner BJ, Huang C, Shah AD, Schittenhelm RB, Nicolazzo JA. Altered Blood-Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis. Pharmaceutics. 14. PMID 36559296 DOI: 10.3390/pharmaceutics14122803 |
0.364 |
|
2021 |
Newman SA, Pan Y, Short JL, Nicolazzo JA. Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells. Pharmaceutical Research. PMID 33532991 DOI: 10.1007/s11095-021-03006-y |
0.358 |
|
2020 |
Jin L, Pan Y, Tran NLL, Polychronopoulos LN, Warrier A, Brouwer KLR, Nicolazzo JA. Intestinal permeability and oral absorption of selected drugs are reduced in a mouse model of familial Alzheimer's disease. Molecular Pharmaceutics. PMID 32212738 DOI: 10.1021/Acs.Molpharmaceut.9B01227 |
0.419 |
|
2020 |
Low YL, Jin L, Morris ER, Pan Y, Nicolazzo JA. Pioglitazone increases blood-brain barrier expression of fatty acid-binding protein 5 and docosahexaenoic acid trafficking into the brain. Molecular Pharmaceutics. PMID 31944767 DOI: 10.1021/Acs.Molpharmaceut.9B01131 |
0.503 |
|
2019 |
Pan Y, Omori K, Ali I, Tachikawa M, Terasaki T, Brouwer KLR, Nicolazzo JA. Increased expression of renal drug transporters in a mouse model of familial Alzheimer's disease. Journal of Pharmaceutical Sciences. PMID 30825461 DOI: 10.1016/J.Xphs.2019.02.016 |
0.414 |
|
2019 |
McInerney MP, Pan Y, Volitakis I, Bush AI, Short JL, Nicolazzo JA. The effects of clioquinol on P-glycoprotein expression and biometal distribution in the mouse brain microvasculature. Journal of Pharmaceutical Sciences. PMID 30738852 DOI: 10.1016/J.Xphs.2019.01.030 |
0.431 |
|
2018 |
Pan Y, Omori K, Ali I, Tachikawa M, Terasaki T, Brouwer KLR, Nicolazzo JA. Altered expression of small intestinal drug transporters and hepatic metabolic enzymes in a mouse model of familial Alzheimer's disease. Molecular Pharmaceutics. PMID 30074800 DOI: 10.1021/Acs.Molpharmaceut.8B00500 |
0.426 |
|
2018 |
Pan Y, Nicolazzo JA. Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics. Advanced Drug Delivery Reviews. PMID 29665383 DOI: 10.1016/J.Addr.2018.04.009 |
0.342 |
|
2018 |
Pan Y, Morris ER, Scanlon MJ, Marriott PJ, Porter CJ, Nicolazzo JA. Dietary Docosahexaenoic Acid Supplementation Enhances Expression of Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier and Brain Docosahexaenoic Acid Levels. Journal of Neurochemistry. PMID 29582413 DOI: 10.1111/Jnc.14342 |
0.495 |
|
2018 |
Pan Y, Short JL, Newman SA, Choy KHC, Tiwari D, Yap C, Senyschyn D, Banks WA, Nicolazzo JA. Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid. Brain, Behavior, and Immunity. PMID 29545118 DOI: 10.1016/J.Bbi.2018.03.007 |
0.444 |
|
2017 |
Lee GS, Pan Y, Scanlon MJ, Porter CJH, Nicolazzo JA. Fatty acid binding protein 5 mediates the uptake of fatty acids, but not drugs, into human brain endothelial cells. Journal of Pharmaceutical Sciences. PMID 29247738 DOI: 10.1016/J.Xphs.2017.11.024 |
0.455 |
|
2017 |
Pan Y, Choy KHC, Marriott PJ, Chai SY, Scanlon MJ, Porter CJH, Short JL, Nicolazzo JA. Reduced Blood-Brain Barrier Expression of Fatty-Acid Binding Protein 5 is associated with Increased Vulnerability of APP/PS1 mice to Cognitive Deficits from Low Omega-3 Fatty Acid Diets. Journal of Neurochemistry. PMID 29105065 DOI: 10.1111/Jnc.14249 |
0.484 |
|
2017 |
Newman SA, Pan Y, Short JL, Nicolazzo JA. Assessing the impact of lithium chloride on the expression of P-glycoprotein at the blood-brain barrier. Journal of Pharmaceutical Sciences. PMID 28093288 DOI: 10.1016/J.Xphs.2017.01.013 |
0.424 |
|
2017 |
McInerney MP, Pan Y, Short JL, Nicolazzo JA. Development and validation of an in-cell western for quantifying P-glycoprotein expression in human brain microvascular endothelial (hCMEC/D3) cells. Journal of Pharmaceutical Sciences. PMID 28065764 DOI: 10.1016/J.Xphs.2016.12.017 |
0.311 |
|
2016 |
Pan Y, Short JL, Choy KH, Zeng AX, Marriott PJ, Owada Y, Scanlon MJ, Porter CJ, Nicolazzo JA. Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 11755-11767. PMID 27852782 DOI: 10.1523/Jneurosci.1583-16.2016 |
0.443 |
|
2015 |
Pan Y, Scanlon MJ, Owada Y, Yamamoto Y, Porter CJ, Nicolazzo JA. Fatty acid-binding protein 5 facilitates the blood-brain barrier transport of docosahexaenoic acid. Molecular Pharmaceutics. PMID 26455443 DOI: 10.1021/Acs.Molpharmaceut.5B00580 |
0.441 |
|
2015 |
Pan Y, Khalil H, Nicolazzo JA. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier? Current Clinical Pharmacology. 10: 222-41. PMID 26338174 DOI: 10.2174/157488471003150820151532 |
0.434 |
|
2014 |
Caon T, Pan Y, Simões CM, Nicolazzo JA. Exploiting the buccal mucosa as an alternative route for the delivery of donepezil hydrochloride. Journal of Pharmaceutical Sciences. 103: 1643-51. PMID 24687969 DOI: 10.1002/Jps.23950 |
0.308 |
|
Show low-probability matches. |